SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-18-000044
Filing Date
2018-11-02
Accepted
2018-11-01 18:06:33
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q032018.htm 10-Q 949132
2 exhibit10_2.htm EX-10.2 37899
3 exhibit10_3.htm EX-10.3 215366
4 ex12.htm EX-12 57077
5 exhibit31_1.htm EX-31 12888
6 exhibit31_2.htm EX-31 12518
7 exhibit32_1.htm EX-32 3333
8 exhibit32_2.htm EX-32 3376
  Complete submission text file 0001367644-18-000044.txt   4426545

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ebs-20180930.xml EX-101.INS 555896
10 XBRL TAXONOMY EXTENSION SCHEMA ebs-20180930.xsd EX-101.SCH 40015
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20180930_cal.xml EX-101.CAL 68811
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20180930_def.xml EX-101.DEF 194658
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20180930_lab.xml EX-101.LAB 571082
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20180930_pre.xml EX-101.PRE 327068
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 181155021
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1